1

Summary

The following educational materials are organized to help differentiate and master the concepts of brain death and coma in a clinical setting.

Comparison Tables for Differential Diagnosis

Table 1: Types of Intracranial Hemorrhage

Table 2: Disorders of Consciousness (DoC)

Table 3: Motor Posturing and Localization

Table 4: Localization of Respiratory Patterns

Flashcard Bullet Points

text

• In the context of trauma, a GCS 3 is interpreted as a critical or comatose state with a very poor prognosis.
• For patients with GCS 6-7, clinicians consider the patient to still have some compensatory potential ("kaya pa").
• A Subdural Hematoma is clinically identified on CT scan by its crescent-shaped appearance that follows the contour of the brain.
• An Epidural Hematoma is distinguished from other bleeds by its lens-shaped or convex appearance on CT.
• In traumatic brain injury, a Midline Shift is the result of mass effect pushing structures from the center to the opposite side.
• For any patient presenting with GCS 3, immediate intubation and ventilatory support are required.
• During the management of head trauma, Cervical Spine Injury must be assumed and the head must not be moved until cleared; manipulation during intubation can worsen the case.
• Mannitol is an osmotic diuretic used to decrease intracranial pressure (ICP); clinicians must monitor urine output, urine osmolality, and electrolytes.
• Hypertonic Saline is used to reduce ICP similarly to Mannitol, necessitating close monitoring of Sodium levels.
• Temporary Hyperventilation to manage ICP aims to maintain CO2 between 30-40 mmHg; CO2 must never drop below 20 mmHg as it can lead to dangerous vasodilation.
• Head Elevation to 30 degrees is a non-medical decompression method used to facilitate venous drainage and decrease ICP.
• In the management of Cerebral Edema, clinicians should prioritize euvolemia and renal function over aggressive fluid reduction to stabilize electrolyte imbalances.
• The Cerebral Perfusion Pressure (CPP) is calculated by subtracting ICP from the Mean Arterial Pressure (MAP).
• The Mean Arterial Pressure (MAP) formula is [Systolic BP + 2(Diastolic BP)] divided by 3.
• A hallmark physical exam finding in Uncal Herniation is ipsilateral anisocoria (unequal pupil size on the same side as the lesion).
• The Brainstem Reflexes assessed for brain death include the pupillary reflex (CN II, III), corneal reflex (CN V), and gag reflex (CN IX, X).
• A Negative Apnea Test, defined as no spontaneous breathing after removal from the ventilator despite hypercapnia, is a critical finding for brain death.
• According to Republic Act No. 7170 (Organ Donation Act), death is defined as the irreversible cessation of cardiac, respiratory, and all brain functions, including the brainstem.
• Brain Death is defined as the irreversible loss of all brain functions, including the brainstem, characterized by coma, absence of brainstem reflexes, and a positive apnea test.
• Informed Consent for a brain death declaration is not mandatory as it is a diagnostic process, but it is encouraged and desirable for legal protection in organ donations.
• For the Brain Death Observation Period, hypothermic patients must be rewarmed to normal temperature before the examination can be validly performed.
• Prerequisites for a Brain Death Examination include an established etiology, irreversibility of vital functions, temperature >38C, and systolic BP >100mmHg (MAP >60mmHg).
• During Brain Death Determination, the two examiners may perform the exam independently, simultaneously, or consecutively.
• Sensorium represents the level and stability of consciousness and is a function of the cerebral cortex and the Activating Reticular System (ARAS).
• The Vegetative State (VS/UWS) is characterized by wakefulness without clinical signs of awareness, often including spontaneous breathing and open eyes.
• Minimally Conscious State (MCS) is differentiated from VS by the presence of minimal, inconsistent but reproducible signs of consciousness, such as following simple commands.
• MCS Plus is a subtype where patients can follow commands, produce intelligible words, or display intentional communication.
• MCS Minus is a subtype where patients show voluntary behaviors like localization to pain or visual pursuit, but no language processing.
• Stupor is a state where a patient can only be transiently awakened by vigorous, noxious stimuli, usually involving withdrawal from the stimulus.
• Hyperactive Delirium is classified as a disorder of mental content/function without a reduced level of consciousness.
• Hypoactive Delirium involves a mildly reduced level of consciousness and is classified as a disorder of arousal.
• Locked-in Syndrome is a coma mimic where the patient is aware but paralyzed, often seen in specific brainstem lesions.
• In the Initial Management of Coma, ABCs must be stabilized, maintaining MAP 60-70, CO2 <40 (but >20), and O2 Sat >90%.
• Flumazenil is the specific reversal agent given to comatose patients suspected of benzodiazepine overdose.
• Raycoon's eyes are a general examination finding suggestive of base of skull fracture in trauma cases.
• In Methanol Poisoning, a fundus examination may reveal a congested and edematous retina with blurred disc margins.
• In Lead Poisoning, greyish deposits may be seen around the optic disc during a fundus examination.
• Terson Syndrome refers to subhyaloid hemorrhage seen in rapid ICP increases, such as Subarachnoid Hemorrhage.
• Papilledema is a diagnostic sign of chronic increased ICP, hypertensive encephalopathy, or intracranial mass lesions.
• Cheyne-Stokes Respiration typically indicates a lesion in the diencephalon, thalamus, or bilateral hemispheres.
• Ataxic Breathing, characterized by an irregular and gasping pattern, localizes the lesion to the medulla.
• Metabolic Encephalopathy is clinically distinguished by "pinpoint" pupils that remain reactive to light.
• Uncal Herniation causes a dilated and fixed pupil that is unequal to the contralateral side (anisocoria).
• Conjugate Lateral Eye Deviation often localizes to an ipsilateral lesion in the frontal eye fields.
• Ocular Bobbing, involving rapid downward jerks followed by a slow return to mid-position, is specific for an acute pontine lesion.
• Ocular Dipping (inverse ocular bobbing) involves an initial slow downward phase followed by a rapid return.
• Before performing the Oculocephalic Reflex (Doll’s Eye) maneuver, cervical spine injury must be strictly excluded.
• During Caloric Testing (Vestibulo-ocular reflex), cool water produces a response in the opposite direction, while warm water produces a response in the same direction.
• Metabolic Encephalopathy is associated with normal results on oculocephalic maneuvers and caloric stimulation.
• The FOUR Score is preferred for non-traumatic coma or ventilated/sedated patients as it provides more neurological data than the GCS.
• Each 1-point improvement in the FOUR Score correlates with a 15% decrease in mortality.
• Midazolam infusion can cause pinpoint pupils due to its GABAergic effects.
• Propofol typically constricts the pupil, but the pupil will dilate upon the application of pain.
• Dexmedetomidine is an alpha-2 agonist that causes sedation and amnesia without respiratory depression, allowing patients to be easily aroused.
• For Apnea Test completion, the pCO2 must reach >60 mmHg or show a 20 mmHg increase from baseline post-test.
• The Apnea Test must be stopped immediately if the patient's blood pressure falls below 90 mmHg.
• An Empty Skull Sign on FDG PET imaging is a unique finding that confirms brain death.
• EEG Silence (isoelectric EEG) is a mandatory confirmatory test in many protocols to support clinical brain death diagnosis.
• The Dorsolateral Pons is one of the two primary brainstem sites where a lesion can cause coma.

Distinguishing Similar Entities & Exam Tips

1. Subdural vs. Epidural Hematoma: Subdural is crescent and follows the brain surface (venous); Epidural is lens-shaped and doesn't cross sutures (arterial).
2. VS vs. MCS: VS has eyes open but no "awareness" of environment; MCS shows "minimal" indicators like following a person's movement with eyes or squeezing a hand on command.
3. Decorticate vs. Decerebrate Posturing: Flexion (Decorticate) is "higher up" (Midbrain); Extension (Decerebrate) is "lower down" (Pons/Medulla) and much worse.
4. Pupils in Metabolic vs. Pontine Lesions: Both can be small, but Metabolic pupils usually "react" to light; Pontine pupils are often "pinpoint and fixed."
5. Ocular Bobbing vs. Ocular Dipping: Bobbing is "Fast Down, Slow Up" (Pontine); Dipping is "Slow Down, Fast Up."
6. GCS vs. FOUR Score: Use GCS for trauma; use FOUR Score for patients on ventilators or those who are heavily sedated.
7. Doll’s Eye vs. Caloric Test: Doll’s eye involves moving the head (unsafe if C-spine isn't cleared); Caloric test uses water in the ear and is safer in trauma once the eardrum is verified intact.
8. Hypoactive Delirium vs. Coma: Delirious patients have a disturbance in "attention"; comatose patients have a total loss of "arousability."
9. Apneustic vs. Ataxic Breathing: Apneustic is a pause at full inspiration (Pons); Ataxic is completely random and unpredictable (Medulla - terminal).
10. Anisocoria in Uncal Herniation: The dilated pupil is on the same side (ipsilateral) as the mass lesion due to CN III compression.

QA

text TYPES OF INTRACRANIAL HEMORRHAGE

1. What is the CT shape of a Subdural Hematoma? | Crescent-shaped
2. What is the CT shape of an Epidural Hematoma? | Convex; lens-shaped
3. What is the vascular source of a Subdural Hematoma? | Bridging veins
4. What is the vascular source of an Epidural Hematoma? | Middle meningeal artery
5. Is Midline Shift common in Subdural and Epidural Hematomas? | Yes (due to mass effect)

DISORDERS OF CONSCIOUSNESS (DoC) 6. Describe awareness in Coma. | Absent 7. Describe awareness in Vegetative State (VS/UWS). | Absent 8. Describe awareness in Minimally Conscious State (MCS). | Minimal but inconsistent 9. Is wakefulness present in Coma? | Absent 10. Is wakefulness present in Vegetative State (VS/UWS)? | Present (eyes open) 11. Is wakefulness present in Minimally Conscious State (MCS)? | Present 12. Is there a sleep-wake cycle in Coma? | Absent 13. Is there a sleep-wake cycle in Vegetative State (VS/UWS)? | Present 14. Is there a sleep-wake cycle in Minimally Conscious State (MCS)? | Present 15. How is command following in Coma? | None 16. How is command following in Vegetative State (VS/UWS)? | None 17. How is command following in Minimally Conscious State (MCS Plus)? | Present 18. Describe communication in Coma. | None 19. Describe communication in Vegetative State (VS/UWS). | None 20. Describe communication in Minimally Conscious State (MCS). | Functional or verbalization possible

MOTOR POSTURING AND LOCALIZATION 21. What is the presentation of Decorticate Posturing? | Arms flexed; legs extended 22. What is the presentation of Decerebrate Posturing? | All extremities extended 23. Where is the lesion in Decorticate Posturing? | Upper midbrain 24. Where is the lesion level in Decerebrate Posturing? | Medulla / Upper pons 25. What is the GCS Motor score for Decorticate Posturing? | GCS Motor 3 26. What is the GCS Motor score for Decerebrate Posturing? | GCS Motor 2 27. Which posturing has a worse prognosis: Decorticate or Decerebrate? | Decerebrate

RESPIRATORY PATTERNS 28. What is the localizing site for Cheyne-Stokes respiration? | Diencephalon 29. What is the localizing site for Central Neurogenic Hyperventilation? | Midbrain or Upper Pons 30. What is the localizing site for Apneustic breathing? | Midbrain / Pons 31. What is the localizing site for Ataxic breathing? | Medulla 32. What is the description for Cheyne-Stokes respiration? | Crescendo-decrescendo with apnea 33. What is the description for Central Neurogenic Hyperventilation? | Rapid, deep breathing 34. What is the description for Apneustic breathing? | Paused inspiration 35. What is the description for Ataxic breathing? | Irregular, gasping

CLINICAL BULLET POINTS: TRAUMA & ICP 36. What is the clinical interpretation of GCS 3 in trauma? | Critical or comatose state 37. What is the compensatory potential for GCS 6-7? | Kaya pa 38. Clinically identify Subdural Hematoma on CT scan. | Crescent-shaped 39. Clinically identify Epidural Hematoma on CT scan. | Lens-shaped; convex 40. Define Midline Shift in traumatic brain injury. | Mass effect pushing structures 41. What is the immediate management for GCS 3? | Intubation; ventilatory support 42. What injury must be assumed in head trauma until cleared? | Cervical Spine Injury 43. What is the risk of head manipulation in Cervical Spine Injury? | Worsen the case 44. Name the osmotic diuretic used to decrease Intracranial Pressure (ICP). | Mannitol 45. In Mannitol use, what should clinicians monitor? (3) | 1) Urine output
2) Urine osmolality
3) Electrolytes 46. What fluid besides Mannitol reduces Intracranial Pressure (ICP)? | Hypertonic Saline 47. What electrolyte requires monitoring with Hypertonic Saline? | Sodium 48. What is the target CO2 for temporary Hyperventilation in ICP? | 30-40 mmHg 49. CO2 must never drop below what level in Hyperventilation? | 20 mmHg 50. What is a non-medical method to decrease Intracranial Pressure (ICP)? | Head elevation (30 degrees) 51. What does 30-degree Head Elevation facilitate? | Venous drainage 52. In Cerebral Edema management, what should be prioritized? | Euvolemia; renal function 53. How is Cerebral Perfusion Pressure (CPP) calculated? | MAP minus ICP 54. State the formula for Mean Arterial Pressure (MAP). | [Systolic + 2(Diastolic)] / 3 55. What is the hallmark finding in Uncal Herniation? | Ipsilateral anisocoria

BRAIN DEATH & NEUROLOGICAL REFLEXES 56. Enumerate the Brainstem Reflexes assessed for brain death. (3) | 1) Pupillary
2) Corneal
3) Gag reflex 57. Which Cranial Nerves are tested in the Pupillary reflex? | CN II, III 58. Which Cranial Nerve is tested in the Corneal reflex? | CN V 59. Which Cranial Nerves are tested in the Gag reflex? | CN IX, X 60. Define a Negative Apnea Test. | No spontaneous breathing 61. What is the legal name of Republic Act No. 7170? | Organ Donation Act 62. How does RA 7170 define death? | Irreversible cessation of cardiac/respiratory/brain 63. What are the three hallmarks of Brain Death? | Coma; absent reflexes; apnea 64. Is Informed Consent mandatory for brain death declaration? | No (it is diagnostic) 65. Requirement for Hypothermic patients before brain death exam? | Rewarm to normal temperature 66. Temperature requirement for Brain Death Examination? | > 38C 67. Blood pressure prerequisites for Brain Death Examination? | Systolic >100; MAP >60 68. How many examiners perform Brain Death Determination? | Two examiners 69. What functional components represent the Sensorium? | Cerebral cortex; ARAS

DISORDERS OF CONSCIOUSNESS SUBTYPES 70. Define the Vegetative State (VS/UWS). | Wakefulness without awareness 71. How is Minimally Conscious State (MCS) differentiated from VS? | Minimal, inconsistent reproducible consciousness 72. Enumerate signs of MCS Plus. (3) | 1) Follows commands
2) Intelligible words
3) Intentional communication 73. Enumerate behaviors in MCS Minus. (2) | 1) Pain localization
2) Visual pursuit 74. Define a state of Stupor. | Transiently awakened by noxious stimuli 75. Classify Hyperactive Delirium. | Disorder of mental content 76. Classify Hypoactive Delirium. | Disorder of arousal 77. Define Locked-in Syndrome. | Aware but paralyzed

INITIAL STABILIZATION & COMPLICATIONS 78. What MAP should be maintained in Initial Management of Coma? | MAP 60-70 79. What O2 Saturation is required in Coma Management? | > 90% 80. What is the reversal agent for Benzodiazepine overdose? | Flumazenil 81. What do Raccoon's eyes suggest? | Base of skull fracture 82. Fundus finding in Methanol Poisoning? | Congested retina; blurred disc 83. Fundus finding in Lead Poisoning? | Greyish deposits around disc 84. Define Terson Syndrome. | Subhyaloid hemorrhage 85. What is Papilledema a diagnostic sign of? | Chronic increased ICP 86. Where does Cheyne-Stokes Respiration localize? | Diencephalon; bilateral hemispheres 87. Where does Ataxic Breathing localize? | Medulla 88. What pupil finding distinguishes Metabolic Encephalopathy? | Pinpoint but reactive 89. Pupil finding in Uncal Herniation? | Dilated and fixed (anisocoria) 90. Localization of Conjugate Lateral Eye Deviation? | Ipsilateral frontal eye fields 91. Describe Ocular Bobbing. | Rapid down; slow return 92. Describe Ocular Dipping. | Slow down; rapid return 93. Condition to exclude before Oculocephalic Reflex (Doll’s Eye)? | Cervical spine injury 94. Direction of response in Caloric Testing? | Cool opposite; Warm same

COMA SCALES & PHARMACOLOGY 95. Eye reflex results in Metabolic Encephalopathy? | Normal maneuvers/caloric stimulation 96. When is the FOUR Score preferred over GCS? | Ventilated or sedated patients 97. Mortality correlate for a 1-point improvement in FOUR Score? | 15% decrease 98. What pupil change is caused by Midazolam? | Pinpoint pupils 99. What pupil change is caused by Propofol? | Constricts pupils 100. Name the alpha-2 agonist used for Sedation without respiratory depression. | Dexmedetomidine

APNEA TEST & CONFIRMATION 101. What pCO2 confirms Apnea Test completion? | > 60 mmHg 102. When must the Apnea Test be stopped immediately? | BP below 90 mmHg 103. What PET finding confirms Brain Death? | Empty Skull Sign 104. What EEG finding supports Brain Death diagnosis? | EEG Silence (isoelectric) 105. Brainstem site where a lesion causes Coma? | Dorsolateral Pons

DISTINGUISHING ENTITIES & TIPS 106. Compare source of Subdural vs. Epidural Hematoma. | Subdural (Venous) vs Epidural (Arterial) 107. Compare awareness in VS vs. MCS. | VS (Absent) vs MCS (Minimal) 108. Compare Decorticate vs. Decerebrate lesion level. | High (Midbrain) vs Low (Pons/Medulla) 109. Metabolic vs. Pontine pupils light reaction? | Metabolic (Reactive) vs Pontine (Fixed) 110. Bobbing vs. Dipping timing? | Bobbing (Fast Down) vs Dipping (Slow Down) 111. Doll’s Eye vs. Caloric Test safety in trauma? | Caloric test is safer 112. Delirium vs. Coma primary disturbance? | Attention (Delirium) vs Arousability (Coma) 113. Apneustic vs. Ataxic breathing pattern? | Pause (Apneustic) vs Random (Ataxic) 114. Side of Anisocoria in Uncal Herniation? | Same side (Ipsilateral)

2

Summary

text

General Neuromuscular Principles

• The lower motor neuron (LMN) unit encompasses the anterior horn cell, the peripheral motor nerve, the neuromuscular junction, and the muscle fiber.
• In Neuromuscular disorders, the distribution of weakness, presence of sensory deficits, and status of deep tendon reflexes (DTRs) are the primary tools for localization.
• Sensory deficits combined with increased DTRs suggest a spinal cord lesion rather than an LMN disorder.
• Bulbar and ocular muscle involvement specifically suggests a Neuromuscular Junction (NMJ) disorder like Myasthenia Gravis.

Amyotrophic Lateral Sclerosis (ALS)

• Amyotrophic Lateral Sclerosis (ALS) is identified as the most common progressive motor neuron disease and the most devastating neurodegenerative disorder.
• The Pathologic hallmark of ALS is the simultaneous death of LMNs in the spinal cord/brainstem and UMNs in layer 5 of the motor cortex*.
• In ALS Pathology, a remarkable feature is the selectivity of neuronal involvement, sparing ocular motility, sacral parasympathetic neurons (bowel/bladder), and sensory apparatus*.
• Spheroids in ALS are focal enlargements in proximal motor axons caused by accumulations of neurofilaments and proteins.
• LMN dysfunction in ALS presents as insidious asymmetric distal limb weakness, cramping during volitional movements, and progressive wasting/atrophy.
• Hand extensors are typically weaker than flexors in patients suffering from ALS.
• Fasciculations, which are involuntary contractions of muscle fibers, are best seen in ALS.
• Pseudobulbar affect in ALS is characterized by involuntary excess in weeping or laughing, caused by bilateral corticobulbar tract lesions.
• The Definite ALS Diagnosis requires evidence of UMN and LMN involvement in 3 out of 4 regions: bulbar, cervical, thoracic, and lumbosacral.
• ALS Epidemiology shows a median survival of only 3-5 years, with death usually resulting from respiratory paralysis.
• Riluzole is a pharmacological treatment for ALS that is known to prolong survival.
• ALS with Frontotemporal Dementia (FTD) is the specific variant where cognitive functions are not spared.

Myasthenia Gravis (MG)

• Myasthenia Gravis (MG) is a neuromuscular junction disorder defined by the cardinal features of weakness and fatigability of skeletal muscles.
• Fatigability in MG is defined as muscle weakness that worsens with repeated use and improves with rest.
• The Fundamental defect in Myasthenia Gravis is an antibody-mediated attack on nicotinic acetylcholine receptors (AChR), decreasing the number of available receptors at the postsynaptic fold.
• Anti-AChR antibodies are the most common antibodies causing MG, found in 85% of generalized cases.
• The Thymus gland is abnormal in 75% of AChR-positive MG patients, with 10% having a thymoma.
• Ptosis is one of the earliest clinical manifestations of MG because the eyes are always open and moving, making them highly susceptible to fatigability*.
• Cranial muscle involvement in MG leads to a "snarling" facial expression, nasal speech, and difficulty swallowing.
• Ocular MG is restricted to extraocular muscles; if it stays restricted for 3 years, it is unlikely to generalize.
• The Ice Pack Test for MG works because cold reduces the activity of acetylcholinesterase, improving ptosis.
• Repetitive Nerve Stimulation (RNS) in MG shows a >10% reduction in Muscle Action Potential (MAP) amplitude at rates of 2-3 stimuli per second.
• Edrophonium (Tensilon) is used for the Anticholinesterase Test due to its rapid onset (30s) and short duration (5 min).
• Pyridostigmine is the most widely used anticholinesterase medication for MG, with an onset of 15-30 minutes.
• Thymectomy is indicated for all patients with thymoma and for many AChR-positive non-thymomatous MG patients to improve long-term strength.
• Allopurinol must be avoided in patients taking Azathioprine for MG due to the risk of severe bone marrow suppression.
• Myasthenic Crisis is a life-threatening exacerbation of weakness causing respiratory failure, most commonly triggered by intercurrent infection.

Duchenne and Becker Muscular Dystrophy (DMD/BMD)

• Duchenne Muscular Dystrophy (DMD) is the most common hereditary neuromuscular disease, affecting 1 in 3,600 liveborn boys.
• The Dystrophin gene, located at Xp21, is the largest human gene; its absence causes DMD.
• Gowers sign is a classic finding in DMD where the child use their hands to "climb up" their legs to stand due to pelvic girdle weakness.
• Calf pseudohypertrophy in DMD is caused by the proliferation of connective tissue and fat, not muscle.
• Intellectual impairment is seen in ALL patients with DMD, though the severity varies.
• Serum Creatine Kinase (CK) in DMD is greatly elevated (15,000–35,000 IU/L); a normal CK is incompatible with the diagnosis unless it's the terminal stage.
• DMD mortality usually occurs in the late teens to 20s due to respiratory failure or cardiomyopathy.
• Becker Muscular Dystrophy (BMD) is a milder variant of DMD where dystrophin is semi-functional rather than absent, leading to later onset and longer life expectancy.
• Glucocorticoid therapy (Prednisone) is the mainstay for DMD to slow the decline of muscle strength and delay scoliosis.

Spinal Muscular Atrophy (SMA)

• Spinal Muscular Atrophy (SMA) is a degenerative disease of the lower motor neurons caused by a homozygous deletion in the SMN1 gene at 5q13.
• SMA Type 1 (Werdnig-Hoffmann) is the most common phenotype, presenting before age 6 months with severe hypotonia and "frog-leg" posture.
• Tongue fasciculations are a specific and important clinical sign of denervation in SMA Type 1.
• SMA Type 1 patients typically never achieve head control and die within the first 2 years without ventilatory support.
• The Diaphragm and Extraocular muscles are notably spared in SMA Type 1.
• SMA Type 2 patients can sit but never walk, while SMA Type 3 (Kugelberg-Welander) patients are able to walk but may lose the ability later.
• Polyminimyoclonus in SMA is a fine tremor of outstretched fingers caused by fasciculations.
• The SMN2 gene copy number is inversely correlated with the clinical severity of SMA (more SMN2 = milder disease).

Pathologic/Diagnostic Differentiations

• Lambert-Eaton Myasthenic Syndrome (LEMS) is a presynaptic disorder distinguished from MG by depressed DTRs and autonomic changes (dry mouth/impotence).
• LEMS Electrophysiology shows an incremental response (increase in amplitude) on high-frequency stimulation, unlike the decrement seen in MG.
• Botulism is a toxin-mediated NMJ disorder that presents with myasthenia-like weakness but includes early autonomic findings and a reduction in CMAP.
• Muscle Contractures differ from cramps because they are associated with energy failure (glycolytic disorders) and show electrical silence on EMG.
• Inclusion Body Myositis is unique due to its asymmetric weakness of the finger flexors and quadriceps.
• Isaac's Syndrome (acquired neuromyotonia) is caused by antibodies against potassium channels, resulting in continuous muscle fiber activity and sweating.
• Stiff-Person Syndrome characteristically involves antibodies against glutamic acid decarboxylase and exhibits muscles that relax during sleep.
• Polymyalgia Rheumatica involves shoulder and hip stiffness in patients >50 years old but has normal CK and EMG, unlike inflammatory myopathies.
• True hypertrophy is seen in Limb-Girdle MD, whereas pseudohypertrophy is the classic feature of DMD.
• Elevated GGT is used to establish that elevated AST/ALT is of liver origin rather than muscle origin.
• Creatine Kinase (CK) is the most sensitive measure of muscle damage, with the MM fraction being specific to skeletal muscle.
• Forearm Exercise Test identifies glycolytic defects if there is an absent rise in lactic acid after vigorous hand exercise.

Distinguishing Similar Entities (Exam High Yield)

• ALS vs. Cervical Cord Compression: Normal cranial nerves and normal radiologic studies of the spine favor ALS, whereas cervical compression often has sensory levels.
• MG vs. LEMS: MG is postsynaptic (AChR) with normal reflexes; LEMS is presynaptic (Ca++ channel) with depressed/absent DTRs and autonomic symptoms.
• MG vs. Botulism: Botulism often presents with early autonomic findings and fixed/dilated pupils, which are absent in MG.
• ALS vs. SMA: ALS involves both UMN and LMN; SMA is strictly an LMN disease.
• DMD vs. BMD: DMD has onset <5 years and <3% dystrophin; BMD has later onset and semi-functional dystrophin.
• Myasthenic Crisis vs. Cholinergic Crisis: Myasthenic crisis is caused by too little medication/infection (improves with Edrophonium); Cholinergic crisis is from overdose (worsens with Edrophonium).
• Asthenia vs. Pathologic Fatigability: Asthenia is a subjective feeling of tiredness; pathologic fatigability (MG) is an objective inability to sustain force.
• Muscle Cramps vs. Myotonia: Cramps are short-duration and triggered by contraction; myotonia is prolonged contraction followed by slow relaxation (difficulty releasing a grip).
• SMA Type 1 vs. SMA Type 3: Type 1 is the most severe (cannot sit, death <2 years); Type 3 is the mildest (can walk into adulthood).
• Fasciculations in SMA vs. DMD: Fasciculations (tongue) are a salient feature of SMA but are characteristically absent in DMD.
• Bulbar Palsy vs. Pseudobulbar Palsy: Bulbar palsy is an LMN lesion of the brainstem; Pseudobulbar palsy is an UMN lesion of the corticobulbar tracts (often showing the pseudobulbar affect).
• MMCB vs. ALS: Multifocal Motor Neuropathy with Conduction Block (MMCB) mimics ALS but is restricted to LMN only and is potentially treatable with IVIG.
• Primary Lateral Sclerosis (PLS) vs. ALS: PLS is purely UMN; ALS must eventually show both UMN and LMN symptoms.
• Ice Pack Test vs. Edrophonium Test: Ice pack test is specifically for ptosis; Edrophonium test can be used for ptosis or limb weakness/dysarthria.
• DMD vs. SMA Type 1 Intelligence: DMD patients frequently have intellectual impairment; SMA patients typically have normal or superior intelligence.
• DMD vs. SMA Type 1 Weakness: DMD weakness starts in toddlerhood (age 2-3); SMA Type 1 weakness is present at birth or within 6 months.
• Post-Poliomyelitis vs. ALS: Post-polio is a delayed deterioration of motor neurons in patients with a history of polio, whereas ALS is uniquely progressive in both UMN/LMN.
• Cramps vs. Contractures (EMG): Cramps show high-frequency motor unit discharges; contractures show electrical silence.
• Myotonia Congenita vs. Myotonic MD: Myotonia congenita involves no prominent weakness; Myotonic MD involves significant muscle weakness and wasting.
• SMA Type 1 Sparing: SMA Type 1 spares the diaphragm, whereas DMD eventually involves and causes failure of the diaphragm.

QA

text

1. What is the pathogenesis of Amyotrophic Lateral Sclerosis (ALS)? | Death of LMN and UMN.
   Involves ubiquitin aggregates and TDP43.
2. What are the clinical manifestations of Amyotrophic Lateral Sclerosis (ALS)? | Asymmetric distal weakness and fasciculations.
   Includes pseudobulbar affect; spares ocular and bladder/bowel.
3. How is a "Definite" diagnosis of Amyotrophic Lateral Sclerosis (ALS) made? | 3 out of 4 regions.
   Requires simultaneous UMN and LMN involvement.
4. What are the pharmacological treatments for Amyotrophic Lateral Sclerosis (ALS)? (2) | Riluzole and Edaravone.
   Riluzole prolongs survival; Edaravone slows worsening.
5. What is the pathogenesis of Myasthenia Gravis (MG)? | Postsynaptic antibody-mediated attack.
   Chiefly Anti-AChR reducing acetylcholine receptors.
6. What are the hallmark clinical manifestations of Myasthenia Gravis (MG)? | Pathologic fatigability.
   Weakness worsens with use; ptosis and diplopia are earliest signs.
7. What diagnostic tests are used for Myasthenia Gravis (MG)? (3) | Ice pack, Edrophonium, RNS.
   Repetitive Nerve Stimulation (RNS) shows >10% decrement.
8. What are the treatment options for Myasthenia Gravis (MG)? (3) | Pyridostigmine, Thymectomy, and Immunotherapy.
   Immunotherapy includes IVIG or Plasmapheresis for crisis.
9. What is the genetic pathogenesis of Duchenne Muscular Dystrophy (DMD)? | X-linked recessive Xp21 mutation.
   Causes absent dystrophin (<3% of normal).
10. What are the classic clinical signs of Duchenne Muscular Dystrophy (DMD)? (3) | Gowers sign, pseudohypertrophy, lordosis.
    Patients are usually non-ambulatory by age 12.
11. How is Duchenne Muscular Dystrophy (DMD) diagnosed? | Elevated CK and genetic testing.
    CK is significantly high (15k-35k IU/L); testing looks for dystrophin gene deletion.
12. What treatments are used for Duchenne Muscular Dystrophy (DMD)? (2) | Glucocorticoids and Exon-skipping.
    Prednisone/Deflazacort delays progression.
13. What is the genetic cause of Spinal Muscular Atrophy (SMA)? | SMN1 gene deletion (5q13).
    Autosomal recessive deletion leading to LMN degeneration.
14. What are the clinical manifestations of Spinal Muscular Atrophy (SMA)? | Symmetrical proximal weakness.
    Includes tongue fasciculations and fine finger tremors.
15. How is Spinal Muscular Atrophy (SMA) definitively diagnosed? | Homozygous SMN1 exon 7 deletion.
    Identified via molecular genetic testing.
16. What are the specialized treatments for Spinal Muscular Atrophy (SMA)? (2) | Nusinersen and Onasemnogene abeparvovec.
    Gene therapy or antisense oligonucleotides (ASO).
17. What components make up the lower motor neuron (LMN) unit? (4) | Anterior horn cell, nerve, NMJ, muscle.
    NMJ refers to the neuromuscular junction.
18. What are the primary tools for localization in Neuromuscular disorders? (3) | Weakness distribution, sensory deficits, DTRs.
    DTRs stand for deep tendon reflexes.
19. In Neuromuscular localization, what do sensory deficits and increased DTRs suggest? | Spinal cord lesion.
    Suggests a central rather than an LMN disorder.
20. Which muscle groups suggest a Neuromuscular Junction (NMJ) disorder when involved? | Bulbar and ocular muscles.
    Highly suggestive of Myasthenia Gravis.
21. Which condition is the most common progressive motor neuron disease? | Amyotrophic Lateral Sclerosis (ALS).
    Considered the most devastating neurodegenerative disorder.
22. What is the pathologic hallmark of Amyotrophic Lateral Sclerosis (ALS)? | Simultaneous LMN and UMN death.
    Occurs in the spinal cord/brainstem and layer 5 motor cortex.
23. What does Amyotrophic Lateral Sclerosis (ALS) characteristically spare? (3) | Ocular motility, bowel/bladder, sensory.
    Spares sacral parasympathetic neurons and sensory apparatus.
24. What are Spheroids in the context of ALS? | Focal axonal enlargements.
    Caused by accumulations of neurofilaments and proteins in proximal motor axons.
25. How does LMN dysfunction in ALS typically present? | Asymmetric distal limb weakness.
    Includes cramping and progressive wasting/atrophy.
26. Which hand muscles are typically weaker in Amyotrophic Lateral Sclerosis (ALS)? | Hand extensors.
    Extensors are typically weaker than flexors.
27. Where are Fasciculations best observed clinically? | ALS.
    These are involuntary contractions of muscle fibers.
28. What causes Pseudobulbar affect in ALS? | Bilateral corticobulbar tract lesions.
    Involuntary excess in weeping or laughing.
29. List the 4 regions assessed for Definite ALS Diagnosis. | Bulbar, cervical, thoracic, lumbosacral.
    Must involve 3 of these 4 regions.
30. What is the median survival for Amyotrophic Lateral Sclerosis (ALS)? | 3 to 5 years.
    Death usually results from respiratory paralysis.
31. What is the pharmacological benefit of Riluzole in ALS? | Prolongs survival.
    It is the standard pharmacological treatment.
32. In which variant of ALS are cognitive functions NOT spared? | ALS with Frontotemporal Dementia (FTD).
    Cognitive functions are usually spared in standard ALS.
33. What are the cardinal clinical features of Myasthenia Gravis (MG)? | Weakness and fatigability.
    Specifically involving skeletal muscles.
34. How is Fatigability defined in Myasthenia Gravis? | Weakness worsening with use.
    Improves with rest.
35. What is the fundamental defect in Myasthenia Gravis (MG)? | Antibody attack on AChRs.
    Reduces available nicotinic acetylcholine receptors at the postsynaptic fold.
36. Which antibody is found in 85% of generalized Myasthenia Gravis (MG) cases? | Anti-AChR antibodies.
    The most common antibodies in MG.
37. What percentage of AChR-positive Myasthenia Gravis patients have a thymoma? | 10 percent.
    75% of patients have some thymus abnormality.
38. Why are Ptosis and Diplopia earliest signs in Myasthenia Gravis? | Susceptibility to fatigability.
    Eyes are always open and moving.
39. What does Cranial muscle involvement in MG lead to? (3) | Snarling expression, nasal speech, dysphagia.
    Dysphagia refers to difficulty swallowing.
40. When is Ocular MG unlikely to generalize? | After 3 years.
    If restricted to extraocular muscles for this duration.
41. What is the physiological basis of the Ice Pack Test in MG? | Cold reduces acetylcholinesterase activity.
    This improves ptosis by increasing available ACh.
42. What result on Repetitive Nerve Stimulation (RNS) is diagnostic for MG? | >10% reduction in MAP.
    Muscle Action Potential amplitude decrease at 2-3 stimuli per second.
43. Why is Edrophonium (Tensilon) used for diagnostic testing? | Rapid onset and short duration.
    Onset in 30 seconds; lasts 5 minutes.
44. What is the most widely used medication for Myasthenia Gravis (MG)? | Pyridostigmine.
    An anticholinesterase with an onset of 15-30 minutes.
45. When is a Thymectomy indicated in MG? | All thymomas; many AChR-positives.
    Used to improve long-term strength.
46. Which drug interaction causes severe bone marrow suppression in Myasthenia Gravis? | Allopurinol and Azathioprine.
    Allopurinol must be avoided in patients on Azathioprine.
47. What is the most common trigger for a Myasthenic Crisis? | Intercurrent infection.
    A life-threatening exacerbation causing respiratory failure.
48. What is the most common hereditary neuromuscular disease? | Duchenne Muscular Dystrophy (DMD).
    Affects 1 in 3,600 liveborn boys.
49. What and where is the Dystrophin gene? | Xp21; largest human gene.
    Its absence causes DMD.
50. Describe the Gowers sign. | Climbing up legs with hands.
    Used to stand up due to pelvic girdle weakness.
51. What causes Calf pseudohypertrophy in DMD? | Connective tissue and fat.
    It is not caused by muscle proliferation.
52. Which system-wide impairment is seen in ALL DMD patients? | Intellectual impairment.
    Severity varies among patients.
53. What is the status of Serum Creatine Kinase (CK) in DMD? | Greatly elevated (15k-35k).
    Normal CK is incompatible with diagnosis (except terminal stage).
54. What are the common causes of DMD mortality? | Respiratory failure or cardiomyopathy.
    Occurs in late teens to 20s.
55. Compare Becker Muscular Dystrophy (BMD) to DMD. | Milder; semi-functional dystrophin.
    Later onset and longer life expectancy.
56. What is the mainstay therapy for Duchenne Muscular Dystrophy? | Glucocorticoids (Prednisone).
    Slows decline and delays scoliosis.
57. What is the pathologic mechanism of Spinal Muscular Atrophy (SMA)? | LMN degeneration.
    Caused by homozygous deletion in SMN1 gene at 5q13.
58. What is the clinical name for SMA Type 1 and its onset? | Werdnig-Hoffmann; before 6 months.
    Presented with severe hypotonia and "frog-leg" posture.
59. What clinical sign in SMA Type 1 specifically indicates denervation? | Tongue fasciculations.
    A specific and important clinical sign.
60. What is the prognosis for SMA Type 1 patients? | Death within 2 years.
    Typically never achieve head control without support.
61. Which muscles are notably spared in SMA Type 1? | Diaphragm and Extraocular muscles.
    Contrast this with other motor neuron diseases.
62. Compare SMA Type 2 vs Type 3 sitting/walking. | Type 2: Sit, never walk.
    Type 3 (Kugelberg-Welander): Walk.
63. Define Polyminimyoclonus in SMA. | Fine tremor of outstretched fingers.
    Caused by fasciculations.
64. How does the SMN2 gene copy number affect SMA? | Inversely correlated with severity.
    More SMN2 copies = milder disease.
65. How is Lambert-Eaton Myasthenic Syndrome (LEMS) distinguished from MG? | Depressed DTRs; autonomic changes.
    LEMS is a presynaptic disorder (dry mouth/impotence).
66. What is the electrophysiologic finding in LEMS? | Incremental response.
    Increase in amplitude on high-frequency stimulation.
67. How does Botulism differ from MG in presentation? | Early autonomic findings; reduced CMAP.
    A toxin-mediated NMJ disorder.
68. How do Muscle Contractures differ from cramps? | Energy failure; electrical silence.
    Associated with glycolytic disorders and silent EMG.
69. What is the unique presentation of Inclusion Body Myositis? | Asymmetric finger flexor/quad weakness.
    Distinctive distribution of weakness.
70. What is the cause of Isaac's Syndrome (acquired neuromyotonia)? | Potassium channel antibodies.
    Continuous muscle fiber activity and sweating.
71. What antibody is associated with Stiff-Person Syndrome? | Anti-GAD (glutamic acid decarboxylase).
    Muscles relax during sleep.
72. Contrast Polymyalgia Rheumatica with inflammatory myopathies. | Normal CK and EMG.
    Involves stiffness in shoulder/hip in patients >50.
73. True hypertrophy vs Pseudohypertrophy: which diseases? | True: Limb-Girdle MD.
    Pseudo: DMD.
74. Why is Elevated GGT measured alongside AST/ALT? | Confirms liver origin.
    Distinguishes liver damage from muscle damage.
75. What is the most sensitive measure of muscle damage? | Creatine Kinase (CK).
    The MM fraction is specific to skeletal muscle.
76. What is identified by an absent rise in lactic acid during a Forearm Exercise Test? | Glycolytic defects.
    Test involves vigorous hand exercise.
77. Distinguish ALS vs. Cervical Cord Compression. | ALS: Normal CNs, normal imaging.
    Cervical compression often has sensory levels.
78. Distinguish MG vs. LEMS by synaptic location and DTRs. | MG: Postsynaptic, normal reflexes.
    LEMS: Presynaptic, depressed/absent reflexes.
79. Distinguish MG vs. Botulism via pupils. | Botulism: Fixed/dilated pupils.
    Absent in MG; Botulism has early autonomic findings.
80. Distinguish ALS vs. SMA by neuron involvement. | ALS: UMN and LMN.
    SMA: LMN only.
81. Distinguish DMD vs. BMD by onset age and dystrophin. | DMD: <5 yrs, absent dystrophin.
    BMD: Later onset, semi-functional dystrophin.
82. Myasthenic vs. Cholinergic Crisis: effect of Edrophonium. | Myasthenic: Improves.
    Cholinergic: Worsens (caused by overdose).
83. Distinguish Asthenia vs. Pathologic Fatigability. | Asthenia: Subjective tiredness.
    Fatigability: Objective inability to sustain force.
84. Distinguish Muscle Cramps vs. Myotonia. | Cramps: Short-duration.
    Myotonia: Prolonged contraction, slow relaxation.
85. Distinguish SMA Type 1 vs. SMA Type 3 by mobility. | Type 1: Cannot sit.
    Type 3: Can walk into adulthood.
86. Where are Fasciculations found comparing SMA and DMD? | Present in SMA; absent in DMD.
    Tongue fasciculations are salient in SMA.
87. Distinguish Bulbar vs. Pseudobulbar Palsy. | Bulbar: LMN (brainstem).
    Pseudobulbar: UMN (corticobulbar tracts).
88. Distinguish MMCB vs. ALS. | MMCB: LMN only, treatable.
    Multifocal Motor Neuropathy with Conduction Block responds to IVIG.
89. Distinguish Primary Lateral Sclerosis (PLS) vs. ALS. | PLS: Purely UMN.
    ALS: Eventually both UMN and LMN.
90. Distinguish Ice Pack vs. Edrophonium Test usage. | Ice pack: Only ptosis.
    Edrophonium: Ptosis, limbs, or dysarthria.
91. Distinguish DMD vs. SMA Type 1 intelligence. | DMD: Intellectual impairment.
    SMA: Normal or superior intelligence.
92. Distinguish DMD vs. SMA Type 1 weakness onset. | DMD: Toddlerhood (2-3 yrs).
    SMA Type 1: Birth or <6 months.
93. Distinguish Post-Poliomyelitis vs. ALS. | Post-polio: Delayed deterioration.
    ALS: Uniquely progressive in both UMN/LMN.
94. Distinguish Cramps vs. Contractures on EMG. | Cramps: High-frequency discharges.
    Contractures: Electrical silence.
95. Distinguish Myotonia Congenita vs. Myotonic MD. | Congenita: No prominent weakness.
    Myotonic MD: Significant weakness/wasting.
96. Compare SMA Type 1 vs. DMD regarding the diaphragm. | SMA Type 1: Sparing.
    DMD: Eventually involves and causes failure.
97. What is the prognostic significance of Riluzole in ALS patients? | Prolongs survival.
    It does not necessarily slow the worsening of symptoms.
98. What is the specific symptom of involuntary excess weeping/laughing in ALS? | Pseudobulbar affect.
    Result of bilateral corticobulbar tract lesions.
99. What are the earliest clinical signs of Myasthenia Gravis? | Ptosis and diplopia.
    Often the very first signs due to eye muscle fatigability.
100. What condition presents with "frog-leg" posture and severe hypotonia at birth? | SMA Type 1.
     Also known as Werdnig-Hoffmann disease.
101. What is the most sensitive skeletal muscle measure? | Creatine Kinase (CK).
     Specifically the MM fraction.
102. Which disorder is characterized by antibodies against calcium channels? | Lambert-Eaton Myasthenic Syndrome (LEMS).
     A presynaptic neuromuscular junction disorder.